TERT and breast cancer: The ten-gene multiplex assay, the TERT singleplex assay, and the aneuploidy assays yielded 52%, 57%, and 28% sensitivities, respectively, when used separately on the BC surveillance cohort (Table 1b and Supplementary file 17, 18 and 19).